Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

dermacann

  • Home
  •  
  • dermacann



  • Most Read
  • Latest Comments
  • Pup got itchy paws? You might want to remember this company’s name
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Pup got itchy paws? You might want to remember this company’s name
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Pup got itchy paws? You might want to remember this company’s name
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Pup got itchy paws? You might want to remember this company’s name
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Pup got itchy paws? You might want to remember this company’s name
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Algorae teams up with HL Pharma to supply cannaboids for research projects
    Algorae teams up with HL Pharma to supply cannaboids for research projects
    • News

  • Neurotech reports clinical trial results for world first Autism Spectrum Disorder drug
    Neurotech reports clinical trial results for world first Autism Spectrum Disorder drug
    • News

  • Little Green Pharma to demerge its medicinal psychedelics business
    Little Green Pharma to demerge its medicinal psychedelics business
    • News

  • Apiam receives regulatory approval for new vaccine against deadly cattle disease
    Apiam receives regulatory approval for new vaccine against deadly cattle disease
    • News

  • Pup got itchy paws? You might want to remember this company’s name
    Pup got itchy paws? You might want to remember this company’s name
    • News

  • Pup got itchy paws? You might want to remember this company’s name
    • News

    Pup got itchy paws? You might want to remember this company’s name

    It wasn’t too long ago that I was in the shower, holding my squirming dog’s paws in a washing basket filled with an oatmeal concoction, whilst smearing peanut butter on the shower wall for her to lick. Why, you ask? Because my baby gets itchy paws (and I’m a great dog mom). Itchy paws and

    Read More
    Public
  • CannPal trials confirm cannabis good for dog health and immunity
    • News

    CannPal trials confirm cannabis good for dog health and immunity

    Animal health company CannPal Animal Therapeutics (ASX: CP1) is proving that the health benefits of medicinal cannabis extend beyond the human realm with their latest trials confirming the safety of DermaCann® as a natural treatment for dermatitis and immune function in canines. Applying two different formulations of DermaCann® between 13 dogs, CannPal reported a substantial

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.